Third View Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.37M Buy
2,049
+111
+6% +$131K 0.28% 80
2026
Q2
$2.32M Buy
1,938
+687
+55% +$702K 0.29% 84
2026
Q1
$1.15M Buy
1,251
+125
+11% +$127K 0.16% 111
2025
Q4
$1.21M Buy
+1,126
New +$1.08M 0.16% 116

Other funds holding LLY

Third View Private Wealth's LLY Position: Q3 2026 in Review

Third View Private Wealth increased its Eli Lilly (LLY) stake by 5.7% in Q3 2026, buying an estimated $131K and bringing the position to 2,049 shares worth $2.37M. The position accounts for 0.28% of the portfolio, ranked #80.

Third View Private Wealth first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Third View Private Wealth held 2,049 shares of Eli Lilly worth $2.37M as of Q3 2026.
  • Third View Private Wealth bought 111 Eli Lilly shares in Q3 2026, an estimated $131K.
  • Eli Lilly made up 0.28% of Third View Private Wealth's portfolio in Q3 2026, its #80 holding.
  • Third View Private Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Third View Private Wealth's 13F filing for Q3 2026, filed 30 Oct 2026.